InterAx Biotech AG, a spin-off of the Paul Scherrer Institute PSI and ETH Zurich, based at PARK INNOVAARE, is building a proprietary systems biology platform...
More details More detailsThe second annual Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction (SPS-XRPD-2) Workshop, organized together with the 16th Pharmaceutical Powder...
More detailsInterAx Biotech AG is a spin off from the ETH Zürich and Paul Scherrer Institute (PSI). The company assists GPCR drug candidate design and selection by...
More detailsThis fall, Dr. Tim Grüne from the Paul Scherrer Institute (PSI) together with Crystallise! AG published the results of their joint project, presenting...
More detailsSwiss Terahertz LLC is implementing some of the globally unique terahertz technologies developed with the new X-ray free-electron laser SwissFEL at the...
More detailsSilicon Valley versus Detroit: What can we learn from the two innovation sites? What caused the former to flourish and the latter to decline? At PARK INNOVAARE...
More detailsSwiss Innovation Forum (#SIF18) – Switzerland's biggest innovation fair – was held on Thursday, November 22, 2018, bringing together over a thousand...
More detailsProfitable innovation does not just happen. It must be managed, measured, and implemented correctly. Robert Shelton, innovation consultant, Executive Fellow...
More detailsThe Business Incubation Centre (BIC) of CERN Technologies, launched this summer by PARK INNOVAARE, CERN, the Paul Scherrer Institute (PSI), and the University...
More detailsCosylab is a globally recognized provider of control systems for particle accelerators. With many years of experience working on highly-complex, demanding...
More detailsToday, the Paul Scherrer Institute (PSI) celebrates its 30th anniversary. The Swiss Federal Council Johann Schneider-Ammann, Aargau Government Council...
More detailsLaunched this summer by PARK INNOVAARE, CERN, the Paul Scherrer Institute (PSI), and the University of Applied Sciences and Arts Northwestern Switzerland...
More details